Please provide your email address to receive an email when new articles are posted on . Age, nulliparity, polyps and shorter sampling intervals may predict endometrial hyperplasia and cancer. Risk ...

Please provide your email address to receive an email when new articles are posted on . Conjugated estrogen/bazedoxifene users had higher endometrial cancer and endometrial hyperplasia rates vs.

Bayer announced today the start of its Phase III study SUNFLOWER, an investigational study evaluating the efficacy and safety of 52mg levonorgestrel-releasing intrauterine system Mirena® for the ...

An Omaha woman diagnosed with endometrial cancer days before her 43rd birthday is now partnering with her oncologist to raise ...

"Endometrial hyperplasia and cancer are highly affected by obesity and lifestyle factors. Focusing on these factors in diverse communities will lead to our better understanding of these disparities.

Despite the increased incidence of endometrial cancer in younger women, there is limited research regarding the safety of local, low-dose vaginal estrogen therapy (ET) for survivors. A new study ...

A study led by Loyola Medicine researchers may help reassure patients who worry the breast cancer drug tamoxifen could increase their risk of uterine cancer. The multi-center study was published in ...

Women who have abnormal bleeding after menopause typically undergo a non-invasive procedure — a transvaginal ultrasound — to look for signs of uterine cancer. But research suggests that test misses ...

Malignant diseases are the second leading cause of death in women. [1] With an incidence of 24 in 100,000, endometrial cancer is the fourth most common cancer in women. [2] When diagnosed at an early ...

WHIPPANY, N.J.--(BUSINESS WIRE)-- Bayer announced today the start of its Phase III study SUNFLOWER, an investigational study evaluating the efficacy and safety of 52mg levonorgestrel-releasing ...